Csenge Advisory Group’s Evogene EVGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-2,076
| Closed | -$13.5K | – | 721 |
|
|
2024
Q2 | $13.5K | Sell |
2,076
-1,000
| -33% | -$6.51K | ﹤0.01% | 657 |
|
|
2024
Q1 | $23.1K | Hold |
3,076
| – | – | ﹤0.01% | 699 |
|
|
2023
Q4 | $25.8K | Hold |
3,076
| – | – | ﹤0.01% | 652 |
|
|
2023
Q3 | $18K | Buy |
3,076
+20
| +0.7% | +$117 | ﹤0.01% | 631 |
|
|
2023
Q2 | $32.7K | Buy |
3,056
+600
| +24% | +$6.42K | ﹤0.01% | 646 |
|
|
2023
Q1 | $15.5K | Sell |
2,456
-500
| -17% | -$3.15K | ﹤0.01% | 593 |
|
|
2022
Q4 | $20.7K | Sell |
2,956
-240
| -8% | -$1.68K | ﹤0.01% | 592 |
|
|
2022
Q3 | $27K | Hold |
3,196
| – | – | ﹤0.01% | 604 |
|
|
2022
Q2 | $24K | Sell |
3,196
-450
| -12% | -$3.38K | ﹤0.01% | 565 |
|
|
2022
Q1 | $47K | Buy |
3,646
+776
| +27% | +$10K | ﹤0.01% | 621 |
|
|
2021
Q4 | $96K | Sell |
2,870
-600
| -17% | -$20.1K | 0.01% | 539 |
|
|
2021
Q3 | $91K | Buy |
3,470
+600
| +21% | +$15.7K | 0.01% | 565 |
|
|
2021
Q2 | $96K | Buy |
2,870
+500
| +21% | +$16.7K | 0.01% | 542 |
|
|
2021
Q1 | $110K | Buy |
2,370
+720
| +44% | +$33.4K | 0.01% | 485 |
|
|
2020
Q4 | $78K | Buy |
+1,650
| New | +$78K | 0.01% | 426 |
|